Clinical trial
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute…
NCT00342316 · Vastra Gotaland Region, Other · Completed
Key facts
| NCT number | NCT00342316 |
|---|---|
| Title | Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia |
| Official title | Prospective Controlled Clinical Study of Allogeneic Stem Cell Transplantation With Reduced Conditioning (RICT) Versus Best Standard of Care in Acute Myeloid Leukemia (AML)in First Complete Remission (CR) |
| Lead sponsor | Vastra Gotaland Region, Other |
| Collaborators | The Canadian Blood and Marrow Transplant Group Australasian Leukaemia and Lymphoma Group |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Procedure |
| Interventions | Reduced Intensity Conditioning Stem Cell Transplantation |
| Enrollment | 340 |
| Start date | Dec 18, 2003 |
| Primary completion | Jul 5, 2018 |
| Completion | Jul 20, 2018 |
| First posted | Jun 21, 2006 |
| Last update posted | Jan 27, 2020 |
| Countries | Australia, Canada, Estonia, Finland, Germany, Greece, New Zealand, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: